Idenix (IDIX) was bought out 3 weeks after announcing phase 1 of their new hepatitis drug. That was for a buy-out. Negotiating a partnership can be done in 2 days
Right to buy... It means that the higher the stock price is when he exercises (buys) those shares, the more he comes out ahead. Bottom line: he wants the stock price to increase as much as we do!
Yep, the science is very promising.
In the investment world, however, the potential of a buyout must always be there to have real price appreciation. Even an early buyout... Both Milano and the Genzyme guys have engineered buyouts of their previous companies, so that potential IS here with Idera-- positive trial results will cause massing buying and shorts to cover because they know that's where we are heading.
Biotechs that don't get that hoped-for buyout often get punished-- MNKD, DNDN, SVNT, AMRN, etc...and now maybe even KERX? (Some do make it alone, of course,if they have a truly blockbuster drug, like MDVN and PCYC...)
we are at even for the week, right where we started Monday morning. Maybe good market for traders, but much ado about nothing. Bird, you said it would be a rocky ride to $6.09. Maybe you're right.
Hey Drew... A couple of things: always have cash available, in case it does drop to your bottom level. Second, in small biotechs, one never knows when news will come which will trounce TA. So the moral is stay vested but hold some cash just in case.
It really depends on how many pans there are in the fire at the time. If we're partnered with 2055 and/or announced GSO phase I and/or launched 9200 w or w/o a partner all will make a difference.
You worry too much.
Not in CERS now, Bird-- I sold a lot of my non-IDRA positions during yesterday's rally. I'm reducing/getting off margin. I'm so excited about IDRA that I do NOT want to be forced to sell any IDRA shares if the market goes bad for a while...
A guy named Amani has the most shares of IDRA, I think. I'm close to him, then Eduardo.
Nonetheless, it's NOTHING compared to one private investor in CYTR. He's a Florida surgeon who has 100% of his net worth invested in CYTR. He's well known on their message board--and his ownership percentage of the company is so high that it is required SEC public information. His initials are SBP. He is NOT an officer of the company and has no affiliiation with it. He's putting it all on the line!!
The shares are getting locked up, and the tradeable float is decreasing. It shows in the volume.
They are begrudgingly having to bid our stock price up to acquire their shares, and that includes short covering purchases also...
There's a critical subgroup of Lymphoma patients with Kras mutation that PCYC's drug will NOT be effective for, that theoretically, 8400 targets head-on....so we have an unmet need for 8400 in this group, if successful
Critial trial results for XOMA's EYEGUARD trial (for Behcet's Uveitis) is due to be released ANY DAY now...
Since you're an optometrist, you gotta put a few $$$ into it, for sentimental reasons!!
Take a little plunge for the team.